Research & Innovation

Race is currently one factor used in GFR equations. Nephrologist Nwamaka Eneanya wonders if its inclusion may contribute to systemic racism in medicine.

Learn how FMCNA is using artificial intelligence to improve care for people on dialysis and people living with CKD and ESRD.

The benefits of Extracorporeal Membrane Oxygenation (ECMO) for patients who test positive for COVID-19, provide an alternative to mechanical ventilation.

The Center for Disease Control (CDC) encourages people living with chronic kidney disease (CKD), to get a COVID-19 booster shot to increase antibody levels.

Fresenius Medical Care developed its own ultrafiltration controller for fluid management. Dr. Lemuel Rivera Fuentes discusses this breakthrough innovation.

Dr. Jeffrey Hymes explains why COVID-19 boosters are necessary and safe, and why they are so effective to protecting our patients with Kidney Disease.

Ines Dahne-Steuber, president of Spectra laboratories and Dr. Alex Ryder, Spectra's medical director discuss the opening of its new Mississippi Lab.

Real-world evidence can complement existing research in gaining new and valuable insights that improve kidney disease care with Dr. Ficociello and Dr. Winter.

The FDA has approved Korsuva (difelikefalin) for moderate to severe pruritus associated with chronic kidney disease.

While global COVID-19 data confirms that dialysis patients experienced a high rate of hospitalization and death, there has been insufficient research into many issues surrounding individuals with end stage kidney disease.

While current COVID-19 vaccines are very effective, manufacturers are developing strategies to ensure that new vaccines can keep pace with the rapid rate of mutation.

We are driving innovation and transformation in kidney care with research into regenerative medicine, organ transplant, and organ recovery.